Abstract
This thesis describes the concluding research that has been conducted in a large population of (young) adults who were born small for gestational age (SGA). Around 10% of children born SGA, do not experience catch-up growth, which leads to persistent short stature until adulthood. Growth hormone treatment and postponing puberty with gonadotropin-releasing hormone agonist (GnRHa) can lead to sufficient catch-up in height, which results in an adult height within the normal range. However, long-term effects of SGA birth, growth hormone and GnRHa treatment were unknown. We describe long-term effects of SGA birth and these treatments on metabolic and cardiovascular health, body composition, bone mineral density, kidney function, cognition and psychosocial functioning.
| Original language | English |
|---|---|
| Awarding Institution |
|
| Supervisors/Advisors |
|
| Award date | 17 Sept 2021 |
| Place of Publication | Rotterdam |
| Print ISBNs | 978-94-6423-413-8 |
| Publication status | Published - 17 Sept 2021 |
Research programs
- EMC MM-01-54-01
Fingerprint
Dive into the research topics of 'Small for gestational age: Adult metabolic and cardiovascular health and long-term safety of growth hormone treatment'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver